Survivin Expression in Glioblastomas Correlates with Proliferation, but not with Apoptosis

Background: Survivin is expressed in proliferating tissues and in tumors. It is a member of the inhibitory apoptosis protein (IAP) family known to regulate mitosis and to inhibit apoptosis. It has therefore been regarded as a target for therapies. In malignant gliomas it increases with malignancy, e...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2008-01, Vol.28 (1A), p.109-118
Main Authors: MELLAI, Marta, CALDERA, Valentina, PATRUCCO, Alessia, ANNOVAZZI, Laura, SCHIFFER, Davide
Format: Article
Language:English
Subjects:
Apoptosis - physiology
Biological and medical sciences
Cell Growth Processes - physiology
Cell Nucleus - metabolism
Glioblastoma - metabolism
Glioblastoma - pathology
Humans
Immunohistochemistry
Inhibitor of Apoptosis Proteins
Ki-67 Antigen - biosynthesis
Medical sciences
Microtubule-Associated Proteins - biosynthesis
Neoplasm Proteins - biosynthesis
Neurology
Tumors
Tumors of the nervous system. Phacomatoses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Survivin is expressed in proliferating tissues and in tumors. It is a member of the inhibitory apoptosis protein (IAP) family known to regulate mitosis and to inhibit apoptosis. It has therefore been regarded as a target for therapies. In malignant gliomas it increases with malignancy, even though in glioblastomas it does not seem to correlate with outcome. Materials and Methods: Survivin was immunohistochemically studied in 39 selected viable glioblastoma areas belonging to 20 cases which were assayed for apoptosis, using a TUNEL assay, caspase-3, poly(ADP-ribose)polymerase 1 (PARP-1), Bid (BH3-interacting domain death agonist) and with the proliferation index Ki-67/MIB-1 and mitotic index (MI). Results: A positive linear correlation was found between the survivin labelling index (LI) and the Ki-67/MIB-1 LI and MI. No inverse correlation was found with apoptosis. Conclusion: This double behavior can be attributed to mechanisms mediating survivin activity, either as a mitosis regulator and apoptosis inhibitor, and should be taken into account in therapeutic strategies using survivin.
ISSN:0250-7005
1791-7530